WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Monday reported a fourth-quarter loss of $6.2 million, after reporting a profit in the same period a year earlier.The Woodcliff Lake, New Jersey-based company said it had a loss of 48 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 85 cents per share.The specialty pharmaceutical company posted revenue of $42.3 million in the period.For the year, the company reported a loss of $8.6 million, or 66 cents per share, swinging to a loss in the period. Revenue was reported as $171.5 million.For the current quarter ending in April, Eagle Pharmaceuticals expects its per-share earnings to range from $3.80 to $4.10.The company said it expects revenue in the range of $120 million to $130 million for the fiscal first quarter._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX